Subfoveal choroidal thickness after brolucizumab therapy for neovascular age-related macular degeneration: a short-term multicenter study.
Tamashiro T, Tanaka K, Itagaki K, Nakayama M, Maruko I, Wakugawa S, Terao N, Onoe H, Wakatsuki Y, Ogasawara M, Sugano Y, Yamamoto A, Kataoka K, Izumi T, Kawai M, Mori R, Sekiryu T, Okada AA, Iida T, Koizumi H; Japan AMD Research Consortium (JARC).
Tamashiro T, et al. Among authors: sugano y.
Graefes Arch Clin Exp Ophthalmol. 2022 Jun;260(6):1857-1865. doi: 10.1007/s00417-021-05517-1. Epub 2022 Jan 16.
Graefes Arch Clin Exp Ophthalmol. 2022.
PMID: 35034215